350
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Effects of Alpha-Lipoic Acid Supplementation on Inflammatory Biomarkers and Matrix Metalloproteinase-3 in Rheumatoid Arthritis Patients

, MSc, , PhD, , MD, , PhD, , PhD, , MD, , BS & , DVM show all
Pages 310-317 | Received 04 Jan 2014, Accepted 29 Mar 2014, Published online: 09 Mar 2015

REFERENCES

  • Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham C, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD: 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581, 2010.
  • Gabriel SE, Michaud K: Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 11:229, 2009.
  • Oliver JE, Silman AJ: Why are women predisposed to autoimmune rheumatic diseases? Arthritis Res Ther 11:252–260, 2009.
  • Brennan F, McInnes I: Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 118:3537–3545, 2008.
  • Firestein GS: Evolving concepts of rheumatoid arthritis. Nature 423:356–361, 2003.
  • Filippin LI, Vercelino R, Marroni NP, Xavier RM: Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol 152:415–422, 2008.
  • Wood AJJ, O’Dell JR: Therapeutic strategies for rheumatoid arthritis. N Engl J Med 350:2591–2602, 2004.
  • Reed LJ: Multienzyme complexes. Acc Chem Res 7:40–46, 1974.
  • Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM: Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 790:1149–1160, 2009.
  • Lee H, Hughes D: Alpha-lipoic acid modulates NF-κB activity in human monocytic cells by direct interaction with DNA. Exp Gerontol 37:401–410, 2002.
  • Zhang W, Frei B: α-Lipoic acid inhibits TNF-α-induced NF-κB activation and adhesion molecule expression in human aortic endothelial cells. FASEB J 15:2423–2432, 2001.
  • Kiemer AK, Muller C, Vollmar AM: Inhibition of LPS-induced nitric oxide and TNF-α production by α-lipoic acid in rat Kupffer cells and in RAW 264.7 murine macrophages. Immunol Cell Biol 80:550–557, 2002.
  • Lee EY, Lee CK, Lee KU, Park JY, Cho KJ, Cho YS, Lee HR, Moon SH, Moon HB, Yoo B: Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice. Rheumatol Int 27:225–233, 2007.
  • Hah YS, Sung MJ, Lim HS, Jun JS, Jeong YG, Kim HO, Kim J, Hur HJ, Davaatseren M, Kwon DY: Dietary alpha lipoic acid supplementation prevents synovial inflammation and bone destruction in collagen-induced arthritic mice. Rheumatol Int 31:1583–1590, 2010.
  • Lee C, Lee E, Kim Y, Mun S, Moon H, Yoo B: Alpha-lipoic acid inhibits TNF-α induced NF-κB activation through blocking of MEKK1-MKK4-IKK signaling cascades. Int Immunopharmacol 8:362–370, 2008.
  • Bae SC, Jung WJ, Lee EJ, Yu R, Sung MK: Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. J Am Coll Nutr 28:56–62, 2009.
  • Julian LJ: Measures of anxiety: State–Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale–Anxiety (HADS-A). Arthritis Care Res 63:467–472, 2011.
  • Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P: International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395, 2003.
  • IPAQ Research Committee: Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)—Short and Long Forms. 2006. Accessed at: http://www.ipaq.ki.se/scoring.pdf
  • Ziegler D, Nowak H, Kempler P, Vargha P, Low PA: Treatment of symptomatic diabetic polyneuropathy with the antioxidant α-lipoic acid: a meta-analysis. Diabet Med 21:114–121, 2004.
  • Golbidi S, Badran M, Laher I: Diabetes and alpha lipoid acid. Front Pharmaco 2:69, 2011.
  • Abou-Raya A, Abou-Raya S: Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun Rev 5:331–337, 2006.
  • Ramos LF, Kane J, McMonagle E, Le P, Wu P, Shintani A, Ikizler TA, Himmelfarb J: Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease. J Ren Nutr 21:211–218, 2011.
  • Manning PJ, Sutherland WHF, Williams SM, Walker RJ, Berry EA, De Jong SA, Ryalls AR: The effect of lipoic acid and vitamin E therapies in individuals with the metabolic syndrome. Nutr Metab Cardiovasc Dis 23:543–549, 2013.
  • Khabbazi T, Mahdavi R, Safa J, Pour-Abdollahi P: Effects of alpha-lipoic acid supplementation on inflammation, oxidative stress and serum lipid profile levels in patients with end-stage renal disease on hemodialysis. J Ren Nutr 22:244–250, 2012.
  • Sola S, Mir MQS, Cheema F, Khan-Merchant N, Menon RG, Parthasarathy S, Khan BV: Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) Study. Circulation 111:343–348, 2005.
  • Trivedi P, Jena G: Role of α-lipoic acid in dextran sulfate sodium-induced ulcerative colitis in mice: studies on inflammation, oxidative stress, DNA damage and fibrosis. Food Chem Toxicol 59:339–355, 2013.
  • Polat B, Zekai H, Elif C, Abdulmecit A, Emre K, Yasin B, Habip B, Ali S, Tugba Nurcan Y: The effect of alpha-lipoic acid in ovariectomy and inflammation-mediated osteoporosis on the skeletal status of rat bone. Eur J Pharmacol 718:469–474, 2013.
  • Tian Y, Hsieh C, Hsieh Y, Chen Y, Peng Y, Hsieh P: α-Lipoic acid prevents mild portal endotoxaemia-induced hepatic inflammation and βcell dysfunction. Eur J Clin Invest 42:637–648, 2011.
  • Li Q, Verma I: NF-kB regulation in the immune system. Nat Rev Immunol 2:725–734, 2002.
  • Bondeson J, Foxwell B, Brennan F, Feldmann M: Defining therapeutic targets by using adenovirus: blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc Natl Acad Sci USA 96:5668–5673, 1999.
  • Ahn K, Aggarwal B: Transcription factor NF-κB: asensor for smoke and stress signals. Ann N Y Acad Sci 1056:218–233, 2005.
  • Phillips D, Dias H, Kitas G, Griffiths H: Aberrant reactive oxygen and nitrogen species generation in rheumatoid arthritis (RA): causes and consequences for immune function, cell survival, and therapeutic intervention. Antioxid Redox Signal 12:743–785, 2010.
  • Ishibashi T: Molecular hydrogen: new antioxidant and anti-inflammatory therapy for rheumatoid arthritis and related diseases. Curr Pharm Des 19:6375–6381, 2013.
  • Liacini A, Sylvester J, Li W, Zafarullah M: Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-κB) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 21:251–262, 2002.
  • Sen T, Dutta A, Chatterjee A: Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B (MMP-9) by involvement of FAK/ERK/NF [kappa] B and AP-1 in the human breast cancer cell line MDA-MB-231. Anticancer Drugs 21:632–644, 2010.
  • Yamanaka H, Matsuda Y, Tanaka M, Sendo W, Nakajima H, Taniguchi A, Kamatani N: Serum matrix metalloproteinase-3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum 43:852–858, 2000.
  • Young-Min S, Cawston T, Marshall N, Coady D, Christgau S, Saxne T, Robins S, Griffiths I: Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers. Arthritis Rheum 56:3236–3247, 2007.
  • Romas E, Gillespie M, Martin T: Involvement of receptor activator of NF-κB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis. Bone 30:340–346, 2002.
  • Epstein FH, Choy EHS, Panayi GS: Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907–916, 2001.
  • Marracci G, Jones R, McKeon G, Bourdette D: Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J Neuroimmunol 131:104–114, 2002.
  • Morini M, Roccatagliata L, Dell’Eva R, Pedemonte E, Furlan R, Minghelli S, Giunti D, Pfeffer U, Marchese M, Noonan D: α-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. J Neuroimmunol 148:146–153, 2004.
  • Lee H, Na M, Kim W: α-Lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer cells. Nutr Res 30:403–409, 2010.
  • Kim H, Park K, Kim Y, Kwon T, Park J, Lee K, Kim J, Lee I: Alpha-lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-kappaB transcriptional activity. Exp Mol Med 39:106–113, 2007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.